ARTICLE | Company News
SGP receives Rebetol sNDA approval
July 26, 2001 7:00 AM UTC
Schering-Plough (SGP) received FDA approval to market its Rebetol ribavirin nucleoside analog separately from the previously approved combination with Intron A, for hepatitis C virus (HCV) infection. ...